glp 1 drugs for obesity New GLP-1 weight loss are about to ship to more American homes Obesity drug cuts opiate craving
Description
Eissele R, Gke R, Willemer S, et al
F.VaduganathanM.RosenstockJ.et al (2020)
7 Recent data shows that GIP is responsible for a substantial portion of postprandial insulin secretion in T2DM and mild hyperglycemia in early disease
Wegovy (2.4mg per dose, 4 injections) in the U.S., Germany, and Netherlands
In the last 10 to 15 years, discoveries on certain gut peptides that influence insulin secretion related to meal ingestion, namely incretins, have opened up a new paradigm in the treatment of diabetes [4]
